• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小檗碱与聚乙二醇化脂质体阿霉素联合用药对荷 Meth A 肉瘤小鼠的抗癌疗效

Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.

作者信息

Yahuafai Jantana, Asai Tomohiro, Oku Naoto, Siripong Pongpun

机构信息

Natural Products and Integrative Medicine Research Section, Research Division, National Cancer Institute.

Department of Medical Biochemistry, University of Shizuoka School of Pharmaceutical Sciences.

出版信息

Biol Pharm Bull. 2018;41(7):1103-1106. doi: 10.1248/bpb.b17-00989.

DOI:10.1248/bpb.b17-00989
PMID:29962406
Abstract

Berberine, the main isoquinoline alkaloid obtained from traditional plants, e.g., Berberis, Coptis, Coscinium spps., etc., is known to exhibit anticancer activity in vitro and in vivo. In this study, the anticancer potential of berberine combined with PEGylated liposomal doxorubicin (polyethylene glycol (PEG)-lip-DOX) was investigated. At first, the effect of berberine on endothelial cells was examined in vitro by use of human umbilical vein endothelial cells (HUVECs): Berberine inhibited HUVEC growth with an IC at 24 h of about 144 µg/mL and that at 72 h of about 29 µg/mL. In contrast, less than 50 µg/mL berberine inhibited the vascular endothelial growth factor (VEGF) expression to some extent after a 24-h incubation, suggesting that berberine suppressed angiogenic action under the condition of little cytotoxicity. Next, the in vivo anticancer activity of the combination of berberine (intraperitoneally (i.p.)) and PEG-lip-DOX (intravenously (i.v.)) was examined in Meth A sarcoma-transplanted BALB/c mice. The results showed that either berberine or PEG-lip-DOX exhibited antiproliferative activity against Meth A cells. Moreover, treatment with the combination of berberine and PEG-lip-DOX suppressed the tumor growth more strongly than that with berberine or PEG-lip-DOX alone. Based on these findings, the combination cancer chemotherapy with berberine and PEGylated liposomal doxorubicin may be beneficial for the treatment of cancer.

摘要

小檗碱是从传统植物如小檗属、黄连属、古山龙属等植物中提取的主要异喹啉生物碱,已知其在体外和体内均具有抗癌活性。在本研究中,对小檗碱与聚乙二醇化脂质体阿霉素(聚乙二醇(PEG)-脂质体阿霉素)联合使用的抗癌潜力进行了研究。首先,通过人脐静脉内皮细胞(HUVECs)在体外检测小檗碱对内皮细胞的影响:小檗碱抑制HUVEC生长,24小时时的IC约为144μg/mL,72小时时约为29μg/mL。相比之下,孵育24小时后,低于50μg/mL的小檗碱在一定程度上抑制血管内皮生长因子(VEGF)表达,这表明小檗碱在细胞毒性较小的情况下抑制血管生成作用。接下来,在接种了Meth A肉瘤的BALB/c小鼠中检测了小檗碱(腹腔注射(i.p.))和PEG-脂质体阿霉素(静脉注射(i.v.))联合使用的体内抗癌活性。结果表明,小檗碱或PEG-脂质体阿霉素对Meth A细胞均表现出抗增殖活性。此外,小檗碱和PEG-脂质体阿霉素联合治疗比单独使用小檗碱或PEG-脂质体阿霉素更强烈地抑制肿瘤生长。基于这些发现,小檗碱与聚乙二醇化脂质体阿霉素联合进行癌症化疗可能对癌症治疗有益。

相似文献

1
Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.小檗碱与聚乙二醇化脂质体阿霉素联合用药对荷 Meth A 肉瘤小鼠的抗癌疗效
Biol Pharm Bull. 2018;41(7):1103-1106. doi: 10.1248/bpb.b17-00989.
2
In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.聚乙二醇脂质体阿霉素(DOX)对阿霉素耐药荷瘤小鼠的体内抗肿瘤作用:对血管内皮细胞的细胞毒性作用机制
J Control Release. 2009 Jan 5;133(1):4-10. doi: 10.1016/j.jconrel.2008.09.008. Epub 2008 Sep 20.
3
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.CD200 模拟适配体 PEG-M49 显著增强了载多柔比星脂质体在转移性乳腺癌小鼠模型中的治疗效果:这种作用不依赖于 CD200 受体 1。
Cancer Immunol Immunother. 2020 Jan;69(1):103-114. doi: 10.1007/s00262-019-02444-3. Epub 2019 Dec 6.
4
Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.通过联合使用 CXCR4 拮抗剂和脂质体多柔比星进行治疗,增强抗肿瘤和抗转移效率。
J Control Release. 2014 Dec 28;196:324-31. doi: 10.1016/j.jconrel.2014.10.017. Epub 2014 Oct 24.
5
Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[F]Fluorothymidine PET.使用3'-脱氧-3'-[F]氟胸苷PET监测脂质体阿霉素联合脂质体长春瑞滨治疗后的肿瘤反应。
Mol Imaging Biol. 2017 Jun;19(3):408-420. doi: 10.1007/s11307-016-1005-2.
6
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.温和的热刺激从优化的隐形热敏脂质体中释放阿霉素,改善肿瘤内药物递送和疗效。
J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21.
7
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.甘胆酸脂质体剂型提高了聚乙二醇脂质体阿霉素在小鼠结肠癌细胞中的治疗效果。
Sci Rep. 2019 Jul 2;9(1):9527. doi: 10.1038/s41598-019-45974-7.
8
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.聚乙二醇化脂质体包载阿霉素通过被动抗血管生成的抗肿瘤作用在耐药肿瘤中。
Int J Pharm. 2016 Jul 25;509(1-2):178-187. doi: 10.1016/j.ijpharm.2016.05.047. Epub 2016 May 24.
9
Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.工程化的乳腺癌靶向肽配体修饰的脂质体阿霉素及其肽密度对抗癌活性的影响。
Biomaterials. 2013 May;34(16):4089-4097. doi: 10.1016/j.biomaterials.2013.02.019. Epub 2013 Mar 5.
10
Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.十六烷基磷酰胆碱(米替福新)作为协同成分在聚乙二醇化脂质体阿霉素中的应用研究:对携带C26结肠癌和B16F0黑色素瘤的小鼠进行体外和体内评估。
Eur J Pharm Sci. 2015 Dec 1;80:66-73. doi: 10.1016/j.ejps.2015.08.011. Epub 2015 Aug 20.

引用本文的文献

1
The delivery carriers and applications for Xiaobojian.小勃健的递送载体及应用
Discov Nano. 2025 Mar 26;20(1):56. doi: 10.1186/s11671-025-04239-1.
2
Nanoparticle-Based Combination Therapy for Ovarian Cancer.基于纳米颗粒的卵巢癌联合治疗。
Int J Nanomedicine. 2023 Apr 12;18:1965-1987. doi: 10.2147/IJN.S394383. eCollection 2023.
3
Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways.小檗碱:通过调节多种细胞信号通路发挥抗癌作用的重要关注点。
Molecules. 2022 Sep 10;27(18):5889. doi: 10.3390/molecules27185889.
4
Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.小檗碱:其药代动力学特性及在多种血管疾病中的治疗潜力综述
Front Pharmacol. 2021 Nov 3;12:762654. doi: 10.3389/fphar.2021.762654. eCollection 2021.
5
Current Advances in for Gastrointestinal and Other Cancers.胃肠道及其他癌症的当前进展
Front Pharmacol. 2022 Jan 3;12:775084. doi: 10.3389/fphar.2021.775084. eCollection 2021.
6
Current Approaches for Personalized Therapy of Soft Tissue Sarcomas.软组织肉瘤个性化治疗的当前方法
Sarcoma. 2020 Mar 31;2020:6716742. doi: 10.1155/2020/6716742. eCollection 2020.
7
Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization.小檗碱启发的抗癌方法的最新进展:从药物联合治疗到新型制剂技术和衍生化。
Molecules. 2020 Mar 20;25(6):1426. doi: 10.3390/molecules25061426.
8
Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy.以血管内皮生长因子及血管内皮生长因子相关多因子为靶点的植物化学物质作为抗癌疗法
J Clin Med. 2019 Mar 12;8(3):350. doi: 10.3390/jcm8030350.